The N-terminus of the B-chain of insulin may adopt two alternative conformations designated as the T- and R-states. Despite the recent structural insight into insulin-insulin receptor (IR) complexes, the physiological relevance of the T/R transition is still unclear. Hence, this study focused on the rational design, synthesis, and characterization of human insulin analogues structurally locked in expected R- or T-states. Sites B3, B5, and B8, capable of affecting the conformation of the N-terminus of the B-chain, were subjects of rational substitutions with amino acids with specific allowed and disallowed dihedral φ and ψ main-chain angles. α-Aminoisobutyric acid was systematically incorporated into positions B3, B5, and B8 for stabilization of the R-state, and N-methylalanine and d-proline amino acids were introduced at position B8 for stabilization of the T-state. IR affinities of the analogues were compared and correlated with their T/R transition ability and analyzed against their crystal and nuclear magnetic resonance structures. Our data revealed that (i) the T-like state is indeed important for the folding efficiency of (pro)insulin, (ii) the R-state is most probably incompatible with an active form of insulin, (iii) the R-state cannot be induced or stabilized by a single substitution at a specific site, and (iv) the B1-B8 segment is capable of folding into a variety of low-affinity T-like states. Therefore, we conclude that the active conformation of the N-terminus of the B-chain must be different from the "classical" T-state and that a substantial flexibility of the B1-B8 segment, where GlyB8 plays a key role, is a crucial prerequisite for an efficient insulin-IR interaction.

Institute of Organic Chemistry and Biochemistry Academy of Sciences of the Czech Republic v v i Flemingovo nám 2 166 10 Prague 6 Czech Republic

Zobrazit více v PubMed

Steiner D. F.; Chan S. J.; Welsh J. M.; Kwok S. C. (1985) Structure and evolution of the insulin gene. Annu. Rev. Genet. 19, 463–484. PubMed

Baker E. N.; Blundell T. L.; Cutfield J. F.; Cutfield S. M.; Dodson E. J.; Dodson G. G.; Hodgkin D. M.; Hubbard R. E.; Isaacs N. W.; Reynolds C. D. (1988) The structure of 2Zn pig insulin crystals at 1.5 Å resolution. Philos. Trans. R. Soc. London, Ser. B 319, 369–456. PubMed

Mirmira R. G.; Nakagawa S. H.; Tager H. S. (1991) Importance of the character and configuration of residues B24, B25, and B26 in insulin-receptor interactions. J. Biol. Chem. 266, 1428–1436. PubMed

Nakagawa S. H.; Tager H. S. (1987) Role of the COOH-terminal B-chain domain in insulin-receptor interactions. Identification of perturbations involving the insulin mainchain. J. Biol. Chem. 262, 12054–12058. PubMed

Zakova L.; Kazdova L.; Hanclova I.; Protivinska E.; Sanda M.; Budesinsky M.; Jiracek J. (2008) Insulin analogues with modifications at position B26. Divergence of binding affinity and biological activity. Biochemistry 47, 5858–5868. PubMed

Zakova L.; Barth T.; Jiracek J.; Barthova J.; Zorad S. (2004) Shortened insulin analogues: Marked changes in biological activity resulting from replacement of TyrB26 and N-methylation of peptide bonds in the C-terminus of the B-chain. Biochemistry 43, 2323–2331. PubMed

Antolikova E.; Zakova L.; Turkenburg J. P.; Watson C. J.; Hanclova I.; Sanda M.; Cooper A.; Kraus T.; Brzozowski A. M.; Jiracek J. (2011) Non-equivalent Role of Inter- and Intramolecular Hydrogen Bonds in the Insulin Dimer Interface. J. Biol. Chem. 286, 36968–36977. PubMed PMC

De Meyts P.; Whittaker J. (2002) Structural biology of insulin and IGF1 receptors: Implications for drug design. Nat. Rev. Drug Discovery 1, 769–783. PubMed

Pullen R. A.; Lindsay D. G.; Wood S. P.; Tickle I. J.; Blundell T. L.; Wollmer A.; Krail G.; Brandenburg D.; Zahn H.; Gliemann J.; Gammeltoft S. (1976) Receptor-binding region of insulin. Nature 259, 369–373. PubMed

Menting J. G.; Whittaker J.; Margetts M. B.; Whittaker L. J.; Kong G. K. W.; Smith B. J.; Watson C. J.; Zakova L.; Kletvikova E.; Jiracek J.; Chan S. J.; Steiner D. F.; Dodson G. G.; Brzozowski A. M.; Weiss M. A.; Ward C. W.; Lawrence M. C. (2013) How insulin engages its primary binding site on the insulin receptor. Nature 493, 241–245. PubMed PMC

Xu B.; Huang K.; Chu Y. C.; Hu S. Q.; Nakagawa S.; Wang S. H.; Wang R. Y.; Whittaker J.; Katsoyannis P. G.; Weiss M. A. (2009) Decoding the Cryptic Active Conformation of a Protein by Synthetic Photoscanning. J. Biol. Chem. 284, 14597–14608. PubMed PMC

Dodson E. J.; Dodson G. G.; Hubbard R. E.; Reynolds C. D. (1983) Insulin’s structural behavior and its relation to activity. Biopolymers 22, 281–291. PubMed

Jiracek J.; Zakova L.; Antolikova E.; Watson C. J.; Turkenburg J. P.; Dodson G. G.; Brzozowski A. M. (2010) Implications for the active form of human insulin based on the structural convergence of highly active hormone analogues. Proc. Natl. Acad. Sci. U.S.A. 107, 1966–1970. PubMed PMC

Zakova L.; Kletvikova E.; Veverka V.; Lepsik M.; Watson C. J.; Turkenburg J. P.; Jiracek J.; Brzozowski A. M. (2013) Structural integrity of the B24 site in human insulin is important for hormone functionality. J. Biol. Chem. 288, 10230–10240. PubMed PMC

De Meyts P.; Van Obberghen E.; Roth J. (1978) Mapping of the residues responsible for the negative cooperativity of the receptor-binding region of insulin. Nature 273, 504–509. PubMed

Derewenda U.; Derewenda Z.; Dodson E. J.; Dodson G. G.; Reynolds C. D.; Smith G. D.; Sparks C.; Swenson D. (1989) Phenol stabilizes more helix in a new symmetrical zinc insulin hexamer. Nature 338, 594–596. PubMed

Kaarsholm N. C.; Ko H. C.; Dunn M. F. (1989) Comparison of solution structural flexibility and zinc binding domains for insulin, proinsulin, and miniproinsulin. Biochemistry 28, 4427–4435. PubMed

Smith G. D.; Dodson G. G. (1992) The Structure of a Rhombohedral R6 Insulin Hexamer That Binds Phenol. Biopolymers 32, 441–445. PubMed

Choi W. E.; Borchardt D.; Kaarsholm N. C.; Brzovic P. S.; Dunn M. F. (1996) Spectroscopic evidence for preexisting T- and R-state insulin hexamer conformations. Proteins: Struct., Funct., Genet. 26, 377–390. PubMed

Roy M.; Brader M. L.; Lee R. W.; Kaarsholm N. C.; Hansen J. F.; Dunn M. F. (1989) Spectroscopic signatures of the T to R conformational transition in the insulin hexamer. J. Biol. Chem. 264, 19081–19085. PubMed

Shneine J.; Voswinkel M.; Federwisch M.; Wollmer A. (2000) Enhancing the T → R transition of insulin by helix-promoting sequence modifications at the N-terminal B-chain. Biol. Chem. 381, 127–133. PubMed

Wan Z. L.; Huang K.; Hu S. Q.; Whittaker J.; Weiss M. A. (2008) The structure of a mutant insulin uncouples receptor binding from protein allostery: An electrostatic block to the TR transition. J. Biol. Chem. 283, 21198–21210. PubMed PMC

Bentley G.; Dodson E.; Dodson G.; Hodgkin D.; Mercola D. (1976) Structure of insulin in 4-zinc insulin. Nature 261, 166–168. PubMed

Ciszak E.; Smith G. D. (1994) Crystallographic evidence for dual coordination around zinc in the T3R3 human insulin hexamer. Biochemistry 33, 1512–1517. PubMed

Jacoby E.; Kruger P.; Karatas Y.; Wollmer A. (1993) Distinction of Structural Reorganization and Ligand-Binding in the T→ R Transition of Insulin on the Basis of Allosteric Models. Biol. Chem. Hoppe-Seyler 374, 877–885. PubMed

Brzovic P. S.; Choi W. E.; Borchardt D.; Kaarsholm N. C.; Dunn M. F. (1994) Structural asymmetry and half-site reactivity in the T to R allosteric transition of the insulin hexamer. Biochemistry 33, 13057–13069. PubMed

Smith G. D.; Dodson G. G. (1992) Structure of a Rhombohedral R6 Insulin Phenol Complex. Proteins: Struct., Funct., Genet. 14, 401–408. PubMed

Wollmer A.; Rannefeld B.; Johansen B. R.; Hejnaes K. R.; Balschmidt P.; Hansen F. B. (1987) Phenol-Promoted Structural Transformation of Insulin in Solution. Biol. Chem. Hoppe-Seyler 368, 903–911. PubMed

Nakagawa S. H.; Zhao M.; Hua Q. X.; Hu S. Q.; Wan Z. L.; Jia W.; Weiss M. A. (2005) Chiral mutagenesis of insulin. Foldability and function are inversely regulated by a stereospecific switch in the B chain. Biochemistry 44, 4984–4999. PubMed PMC

Weiss M. A. (2009) The Structure and Function of Insulin: Decoding the TR Transition. In Insulin and IGFs (Litwack G., Ed.) pp 33–49, Academic Press, New York. PubMed PMC

Vinther T. N.; Norrman M.; Ribel U.; Huus K.; Schlein M.; Steensgaard D. B.; Pedersen T. A.; Pettersson I.; Ludvigsen S.; Kjeldsen T.; Jensen K. J.; Hubalek F. (2013) Insulin analog with additional disulfide bond has increased stability and preserved activity. Protein Sci. 22, 296–305. PubMed PMC

Hua Q. X.; Nakagawa S.; Hu S. Q.; Jia W.; Wang S.; Weiss M. A. (2006) Toward the active conformation of insulin: Stereospecific modulation of a structural switch in the B chain. J. Biol. Chem. 281, 24900–24909. PubMed

Becker R. H. A. (2007) Insulin glulisine complementing basal insulins: A review of structure and activity. Diabetes Technol. Ther. 9, 109–121. PubMed

Marshall G. R.; Hodgkin E. E.; Langs D. A.; Smith G. D.; Zabrocki J.; Leplawy M. T. (1990) Factors Governing Helical Preference of Peptides Containing Multiple α,α-Dialkyl Amino-Acids. Proc. Natl. Acad. Sci. U.S.A. 87, 487–491. PubMed PMC

Karle I. L.; Balaram P. (1990) Structural Characteristics of α-Helical Peptide Molecules Containing Aib Residues. Biochemistry 29, 6747–6756. PubMed

Ciszak E.; Beals J. M.; Frank B. H.; Baker J. C.; Carter N. D.; Smith G. D. (1995) Role of C-terminal B-chain residues in insulin assembly: The structure of hexameric LysB28ProB29-human insulin. Structure 3, 615–622. PubMed

Wang S. H.; Hu S. Q.; Burke G. T.; Katsoyannis P. G. (1991) Insulin analogues with modifications in the β-turn of the B-chain. J. Protein Chem. 10, 313–324. PubMed

Chance R. E., Hoffmann J. A., Kroeff E. P., Johnson M. G., Schirmer E. W., and Bromer W. W. (1981) The production of human insulin using recombinant DNA technology and a new chain combination procedure. In Proceedings of the 7th American Peptide Symposium (Rich D. H., and Gross E., Eds.) pp 721–728, Pierce Chemical Co., Rockford, IL.

Morcavallo A.; Genua M.; Palummo A.; Kletvikova E.; Jiracek J.; Brzozowski A. M.; Iozzo R. V.; Belfiore A.; Morrione A. (2012) Insulin and Insulin-like Growth Factor II Differentially Regulate Endocytic Sorting and Stability of Insulin Receptor Isoform A. J. Biol. Chem. 287, 11422–11436. PubMed PMC

Swillens S. (1995) Interpretation of Binding Curves Obtained with High Receptor Concentrations: Practical Aid for Computer-Analysis. Mol. Pharmacol. 47, 1197–1203. PubMed

Herrmann T.; Guntert P.; Wuthrich K. (2002) Protein NMR structure determination with automated NOE assignment using the new software CANDID and the torsion angle dynamics algorithm DYANA. J. Mol. Biol. 319, 209–227. PubMed

Guntert P.; Wuthrich K. (1991) Improved efficiency of protein structure calculations from NMR data using the program DIANA with redundant dihedral angle constraints. J. Biomol. NMR 1, 447–456. PubMed

Harjes E.; Harjes S.; Wohlgemuth S.; Muller K. H.; Krieger E.; Herrmann C.; Bayer P. (2006) GTP-Ras disrupts the intramolecular complex of C1 and RA domains of Nore1. Structure 14, 881–888. PubMed

Koradi R.; Billeter M.; Wuthrich K. (1996) MOLMOL: A program for display and analysis of macromolecular structures. J. Mol. Graphics 14, 51–55. PubMed

Doreleijers J. F.; da Silva A. W. S.; Krieger E.; Nabuurs S. B.; Spronk C. A. E. M.; Stevens T. J.; Vranken W. F.; Vriend G.; Vuister G. W. (2012) CING: An integrated residue-based structure validation program suite. J. Biomol. NMR 54, 267–283. PubMed PMC

Winter G. (2010) xia2: An expert system for macromolecular crystallography data reduction. J. Appl. Crystallogr. 43, 186–190.

Bailey S. (1994) The Ccp4 Suite: Programs for Protein Crystallography. Acta Crystallogr. D50, 760–763. PubMed

Emsley P.; Cowtan K. (2004) Coot: Model-building tools for molecular graphics. Acta Crystallogr. D60, 2126–2132. PubMed

Vagin A.; Teplyakov A. (1997) MOLREP: An automated program for molecular replacement. J. Appl. Crystallogr. 30, 1022–1025.

Smith G. D.; Pangborn W. A.; Blessing R. H. (2003) The structure of T-6 human insulin at 1.0 Å resolution. Acta Crystallogr. D59, 474–482. PubMed

Murshudov G. N.; Vagin A. A.; Dodson E. J. (1997) Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr. D53, 240–255. PubMed

Yao Z. P.; Zeng Z. H.; Li H. M.; Zhang Y.; Feng Y. M.; Wang D. C. (1999) Structure of an insulin dimer in an orthorhombic crystal: The structure analysis of a human insulin mutant (B9 Ser → Glu). Acta Crystallogr. D55, 1524–1532. PubMed

Nakagawa S. H.; Tager H. S. (1991) Implications of invariant residue LeuB6 in insulin-receptor interactions. J. Biol. Chem. 266, 11502–11509. PubMed

Sohma Y.; Hua Q. X.; Liu M.; Phillips N. B.; Hu S. Q.; Whittaker J.; Whittaker L. J.; Ng A.; Roberts C. T.; Arvan P.; Kent S. B. H.; Weiss M. A. (2010) Contribution of Residue B5 to the Folding and Function of Insulin and IGF-I. J. Biol. Chem. 285, 5040–5055. PubMed PMC

Hua Q. X.; Liu M.; Hu S. Q.; Jia W. H.; Arvan P.; Weiss M. A. (2006) A conserved histidine in insulin is required for the foldability of human proinsulin: Structure and function of an Ala(B5) analog. J. Biol. Chem. 281, 24889–24899. PubMed

Brange J.; Langkjaer L.; Havelund S.; Volund A. (1992) Chemical-Stability of Insulin. 1. Hydrolytic Degradation during Storage of Pharmaceutical Preparations. Pharmacol. Res. 9, 715–726. PubMed

Huus K.; Havelund S.; Olsen H. B.; de Weert M. V.; Frokjaer S. (2006) Chemical and thermal stability of insulin: Effects of zinc and ligand binding to the insulin zinc-hexamer. Pharmacol. Res. 23, 2611–2620. PubMed

Gauguin L.; Klaproth B.; Sajid W.; Andersen A. S.; McNeil K. A.; Forbes B. E.; De Meyts P. (2008) Structural basis for the lower affinity of the insulin-like growth factors for the insulin receptor. J. Biol. Chem. 283, 2604–2613. PubMed

Kristensen C.; Kjeldsen T.; Wiberg F. C.; Schaffer L.; Hach M.; Havelund S.; Bass J.; Steiner D. F.; Andersen A. S. (1997) Alanine scanning mutagenesis of insulin. J. Biol. Chem. 272, 12978–12983. PubMed

Bajaj M.; Blundell T. L.; Horuk R.; Pitts J. E.; Wood S. P.; Gowan L. K.; Schwabe C.; Wollmer A.; Gliemann J.; Gammeltoft S. (1986) Coypu Insulin: Primary Structure, Conformation and Biological Properties of a Hystricomorph Rodent Insulin. Biochem. J. 238, 345–351. PubMed PMC

Conlon J. M. (2001) Evolution of the insulin molecule: Insights into structure-activity and phylogenetic relationships. Peptides 22, 1183–1193. PubMed

Marki F.; de Gasparo M.; Eisler K.; Kamber B.; Riniker B.; Rittel W.; Sieber P. (1979) Synthesis and biological activity of seventeen analogues of human insulin. Hoppe-Seyler’s Z. Physiol. Chem. 360, 1619–1632. PubMed

Cao Q. P.; Geiger R.; Langner D.; Geisen K. (1986) Biological-Activity In vivo of Insulin Analogs Modified in the N-Terminal Region of the B-Chain. Biol. Chem. Hoppe-Seyler 367, 135–140. PubMed

Liu M.; Haataja L.; Wright J.; Wickramasinghe N. P.; Hua Q. X.; Phillips N. F.; Barbetti F.; Weiss M. A.; Arvan P. (2010) Mutant INS-Gene Induced Diabetes of Youth: Proinsulin Cysteine Residues Impose Dominant-Negative Inhibition on Wild-Type Proinsulin Transport. PLoS One 5, e13333. PubMed PMC

Edghill E. L.; Flanagan S. E.; Patch A. M.; Boustred C.; Parrish A.; Shields B.; Shepherd M. H.; Hussain K.; Kapoor R. R.; Malecki M.; MacDonald M. J.; Stoy J.; Steiner D. F.; Philipson L. H.; Bell G. I.; Hattersley A. T.; Ellard S.; Collaborative N. D. I. (2008) Insulin mutation screening in 1,044 patients with diabetes: Mutations in the INS gene are a common cause of neonatal diabetes but a rare cause of diabetes diagnosed in childhood or adulthood. Diabetes 57, 1034–1042. PubMed PMC

Burke G. T.; Hu S. Q.; Ohta N.; Schwartz G. P.; Zong L.; Katsoyannis P. G. (1990) Superactive insulins. Biochem. Biophys. Res. Commun. 173, 982–987. PubMed

Tang L.; Whittingham J. L.; Verma C. S.; Caves L. S.; Dodson G. G. (1999) Structural consequences of the B5 histidine → tyrosine mutation in human insulin characterized by X-ray crystallography and conformational analysis. Biochemistry 38, 12041–12051. PubMed

Chen H.; Feng Y. M. (2001) Contribution of the residue Glu9, Glu46, and Phe49 to the biological activity of insulin-like growth factor-1. IUBMB Life 51, 33–37. PubMed

Nakagawa S. H., Zhao M., Hua Q. X., and Weiss M. A.. The importance of residue B8 in insulin activity, structure and folding. In Proceedings of the 15th American Peptide Symposium (Tam J. P., and Kaumaya P. T. P., Eds.) pp 471–472, Pierce Chemical Co., Rockford, IL.

Guo Z. Y.; Zhang Z.; Jia X. Y.; Tang Y. H.; Feng Y. M. (2005) Mutational analysis of the ahsolutely conserved B8Gly: Consequence on foldability and activity of insulin. Acta Biochim. Biophys. Sin. 37, 673–679. PubMed

Stoy J.; Steiner D. F.; Park S. Y.; Ye H. G.; Philipson L. H.; Bell G. I. (2010) Clinical and molecular genetics of neonatal diabetes due to mutations in the insulin gene. Rev. Endocr. Metab. Disord. 11, 205–215. PubMed PMC

Stoy J.; Edghill E. L.; Flanagan S. E.; Ye H. G.; Paz V. P.; Pluzhnikov A.; Below J. E.; Hayes M. G.; Cox N. J.; Lipkind G. M.; Lipton R. B.; Greeley S. A. W.; Patch A. M.; Ellard S.; Steiner D. F.; Hattersley A. T.; Philipson L. H.; Bell G. I. (2007) Insulin gene mutations as a cause of permanent neonatal diabetes. Proc. Natl. Acad. Sci. U.S.A. 104, 15040–15044. PubMed PMC

Markussen J.; Diers I.; Engesgaard A.; Hansen M. T.; Hougaard P.; Langkjaer L.; Norris K.; Ribel U.; Sorensen A. R.; Sorensen E. (1987) Soluble, prolonged-acting insulin derivatives. II. Degree of protraction and crystallizability of insulins substituted in positions A17, B8, B13, B27 and B30. Protein Eng. 1, 215–223. PubMed

Zhao M., Nakagawa S. H., Hua Q. X., and Weiss M. A. (1997) Exploring the foldability and function of insulin by combinatorial peptide chemistry. In Proceedings of the 15th American Peptide Symposium (Tam J. P., and Kaumaya P. T. P., Eds.) pp 369–371, Pierce Chemical Co., Rockford, IL.

Brange J. (1997) The new era of biotech insulin analogues. Diabetologia 40, S48–S53. PubMed

Bao S. J.; Xie D. L.; Zhang J. P.; Chang W. R.; Liang D. C. (1997) Crystal structure of desheptapeptide(B24-B30)insulin at 1.6 Å resolution: Implications for receptor binding. Proc. Natl. Acad. Sci. U.S.A. 94, 2975–2980. PubMed PMC

Olsen H. B.; Ludvigsen S.; Kaarsholm N. C. (1996) Solution structure of an engineered insulin monomer at neutral pH. Biochemistry 35, 8836–8845. PubMed

A viral insulin-like peptide inhibits IGF-1 receptor phosphorylation and regulates IGF1R gene expression

Characterization of insulin crystalline form in isolated β-cell secretory granules

Characterization of viral insulins reveals white adipose tissue-specific effects in mice

The efficiency of insulin production and its content in insulin-expressing model β-cells correlate with their Zn2+ levels

A radioligand binding assay for the insulin-like growth factor 2 receptor

Mutations at hypothetical binding site 2 in insulin and insulin-like growth factors 1 and 2 result in receptor- and hormone-specific responses

Probing Receptor Specificity by Sampling the Conformational Space of the Insulin-like Growth Factor II C-domain

Rational steering of insulin binding specificity by intra-chain chemical crosslinking

Structural and functional study of the GlnB22-insulin mutant responsible for maturity-onset diabetes of the young

Human insulin analogues modified at the B26 site reveal a hormone conformation that is undetected in the receptor complex